New Study Links Adolescent Cannabis Exposure to Psychosis Risk
Adolescent cannabis exposure psychosis risk is a critical concern supported by large-scale research. This study highlights the increased vulnerability to psychotic disorders linked to cannabis use during adolescence. Understanding this risk is vital for…
Rapid Dose Therapeutics Advances Cannabinoid Studies for QuickStrip Drug Delivery Platform
Oral thin film cannabinoid delivery is an emerging technology addressing challenges in cannabis medicine. This delivery method offers faster onset and more precise dosing compared to traditional edibles. QuickStrip's platform exemplifies innovation in…
US Cannabis Rescheduling: A Victory or a Federal Trap?
Cannabis federal policy impacts patient access significantly as rescheduling shifts cannabis regulation. This change risks disrupting state medical cannabis programs. Understanding these federal policy impacts is essential for clinicians and patients.
New Study Links Cannabis Use in Teens to Psychosis Risk
A major study highlights cannabis youth psychosis risk, showing that teen cannabis use increases chances of psychotic disorders later. The developing brain is vulnerable to THC effects, raising psychiatric concerns. This research urges caution and…
Teens Using Cannabis Face Increased Mental Health Risks
Teen cannabis use mental health risks are increasingly documented in clinical research. Studies show adolescent cannabis use is linked to higher chances of psychiatric disorders. This underscores the importance of medical supervision and caution with…
A Huge Study Finds a Link Between Cannabis Use in Teens and Psychosis Later – NPR
This large-scale adolescent cannabis study reveals important findings about the link between cannabis use in teens and psychosis risk later in life. The research underscores the vulnerability of the developing brain to cannabinoid exposure. Age of onset,…
Most Cannabis Users Are Non-Problematic, Canadian Data Shows
Canadian data on cannabis use disorder treatment neuroimaging study reveals most cannabis users are non-problematic. This supports clinical observations that responsible cannabis use is common. Understanding these findings helps reduce stigma and informs…
Op-Ed: The Essential Role of Pharmacists in Cannabis Care
Pharmacists cannabis care role is crucial for patient safety in cannabis therapy. Their involvement ensures professional drug interaction checks and standardized dosing advice. Integrating pharmacists into cannabis care fills a critical gap in medication…
The Neuroscience of Cannabis Appetite Stimulation
Cannabis appetite stimulation neuroscience reveals how cannabinoids interact with the brain's endocannabinoid system to increase hunger. Activation of CB1 receptors in the hypothalamus and olfactory regions enhances food perception and overrides satiety.…
IGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial
The Phase 2 CALMA trial expands clinical sites for cannabinoid-based therapy Alzheimer agitation, offering new hope for managing difficult symptoms. This cannabinoid-based therapy Alzheimer agitation approach targets neuroinflammation and behavioral…
